Document Detail


Effect of hyperhomocysteinemia on protein C activation and activity.
MedLine Citation:
PMID:  12200374     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hyperhomocysteinemia has been proposed to inhibit the protein C anticoagulant system through 2 mechanisms: decreased generation of activated protein C (APC) by thrombin, and resistance to APC caused by decreased inactivation of factor Va (FVa). We tested the hypotheses that generation of APC by thrombin is impaired in hyperhomocysteinemia in monkeys and that hyperhomocysteinemia produces resistance to APC in monkeys, mice, and humans. In a randomized crossover study, cynomolgus monkeys were fed either a control diet or a hyperhomocysteinemic diet for 4 weeks. Plasma total homocysteine (tHcy) was approximately 2-fold higher when monkeys were on the hyperhomocysteinemic diet than when they were on the control diet (9.8 +/- 2.0 microM versus 5.6 +/- 1.0 microM; P <.05). After infusion of human thrombin (25 microg/kg of body weight), the peak level of plasma APC was 136 +/- 16 U/mL in monkeys fed the control diet and 127 +/- 13 U/mL in monkeys fed the hyperhomocysteinemic diet (P >.05). The activated partial thromboplastin time was prolonged to a similar extent by infusion of thrombin in monkeys fed the control diet and in those fed the hyperhomocysteinemic diet. The sensitivity of plasma FV to human APC was identical in monkeys on control diet and those on hyperhomocysteinemic diet. We also did not detect resistance of plasma FV to APC in hyperhomocysteinemic mice deficient in cystathionine beta-synthase (plasma tHcy, 93 +/- 16 microM) or in human volunteers with acute hyperhomocysteinemia (plasma tHcy, 45 +/- 6 microM). Our findings indicate that activation of protein C by thrombin and inactivation of plasma FVa by APC are not impaired during moderate hyperhomocysteinemia in vivo.
Authors:
Steven R Lentz; Donald J Piegors; José A Fernández; Rochelle A Erger; Erland Arning; M René Malinow; John H Griffin; Teodoro Bottiglieri; William G Haynes; Donald D Heistad
Related Documents :
7683714 - A depletion-repletion folate bioassay based on growth and tissue folate concentrations ...
7260944 - Effect of diet on excretion of estrogens in pre- and postmenopausal women.
2341914 - Impaired milk folate secretion is not corrected by supplemental folate during iron defi...
21941054 - Relationship of body fat with insulin resistance and cardiometabolic risk factors among...
2839024 - Temporal study of metabolic change when poorly controlled noninsulin-dependent diabetic...
11175494 - Use of nucleotides in weanling rats with diarrhea induced by a lactose overload: effect...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Blood     Volume:  100     ISSN:  0006-4971     ISO Abbreviation:  Blood     Publication Date:  2002 Sep 
Date Detail:
Created Date:  2002-08-29     Completed Date:  2002-10-24     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  7603509     Medline TA:  Blood     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2108-12     Citation Subset:  AIM; IM    
Affiliation:
Department of Internal Medicine, Veterans Affairs Medical Center, C303 GH, University of Iowa, Iowa City, IA 52242, USA. steven-lentz@uiowa.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cystathionine beta-Synthase / blood,  deficiency
Disease Models, Animal
Enzyme Activation
Factor V / drug effects,  metabolism
Female
Haplorhini
Humans
Hyperhomocysteinemia / blood,  enzymology*
Male
Methionine / administration & dosage,  pharmacology
Mice
Mice, Inbred C57BL
Partial Thromboplastin Time
Protein C / metabolism*,  pharmacology
Thrombin / metabolism
Grant Support
ID/Acronym/Agency:
DK 25295/DK/NIDDK NIH HHS; HL 52246/HL/NHLBI NIH HHS; HL 58972/HL/NHLBI NIH HHS; HL 62984/HL/NHLBI NIH HHS; HL 63943/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Protein C; 63-68-3/Methionine; 9001-24-5/Factor V; EC 3.4.21.5/Thrombin; EC 4.2.1.22/Cystathionine beta-Synthase
Comments/Corrections
Comment In:
Blood. 2003 Mar 15;101(6):2446-7   [PMID:  12609965 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Amelioration of the macrothrombocytopenia associated with the murine Bernard-Soulier syndrome.
Next Document:  Normal Arp2/3 complex activation in platelets lacking WASp.